Summary
This narrative review synthesises recent advances in nanoformulation of polyphenol-rich botanical extracts with putative anticancer properties, addressing key limitations of poor solubility, instability, and limited bioavailability that hinder clinical translation. The authors evaluate polymeric nanoparticles, liposomes, solid lipid nanoparticles, and nanoemulsions as delivery systems, emphasising both their potential to improve physicochemical performance and the technical challenges of preserving the compositional integrity and synergistic effects of complex botanical matrices.
Regional applicability
This is a laboratory and formulation-focused review with no geographical research component. Findings on nanoformulation technologies and delivery strategies are internationally applicable and relevant to United Kingdom pharmaceutical and nutraceutical research and development sectors seeking to develop plant-derived anticancer therapeutics.
Key measures
Solubility, stability, bioavailability, encapsulation efficiency, preservation of compositional integrity and synergistic effects across different nanocarrier systems
Outcomes reported
This review examines nanoformulation approaches for polyphenol-rich botanical extracts (hesperidin, naringenin, hydroxytyrosol, oleuropein, quercetin) and their potential to enhance bioavailability and anticancer efficacy. The review evaluates various nanocarrier types and their ability to improve physicochemical properties and protect against degradation.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.